AORT: the cashflow

MyFinsight

For the year ending 2025-12-31, AORT had $11,445K increase in cash & cash equivalents over the period. $839K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-12-31
Net income (loss)	9,768
Depreciation and amortization	22,458
Non-cash compensation	24,385
Non-cash lease expense	5,170
Write-down of inventories and deferred preservation costs	4,900
Non-cash interest expense	1,705
Deferred income taxes	37
Change in fair value of contingent consideration	7,700
Endospan fair value adjustments	-2,337
Losses on inducement/extinguishment of debt	-2,664
Gain from sale of non-financial assets	7,000
Other	-7,409
Receivables	7,269
Inventories and deferred preservation costs	15,277
Prepaid expenses and other assets	1,798
Accounts payable, accrued expenses, and other liabilities	2,183
Net cash flows provided by operating activities	39,880
Capital expenditures	39,041
Payments under endospan agreements	8,000
Proceeds from sale of non-financial assets, net	5,000
Net cash flows used in investing activities	-42,041
Proceeds from issuance of long-term debt	0
Proceeds from revolving credit facility	0
Repayment of debt	210
Proceeds from exercise of stock options and issuance of common stock	13,074
Payment of debt issuance costs	1,750
Proceeds from financing insurance premiums	3,117
Principal payments on short-term notes payable	2,250
Redemption and repurchase of stock to cover tax withholdings	0
Other	-699
Net cash flows provided by financing activities	11,282
Effect of exchange rate changes on cash and cash equivalents	2,324
Increase (decrease) in cash and cash equivalents	11,445
Cash and cash equivalents at beginning of period	53,463
Cash and cash equivalents at end of period	64,908

Unit: Thousand (K) dollars